Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention.

作者: Malú G. Tansey , Matthew S. Goldberg

DOI: 10.1016/J.NBD.2009.11.004

关键词: ImmunologyParkinson's diseaseMicrogliaParkinNeurodegenerationBiologyNeuron deathNeuroscienceNeuroprotectionSubstantia nigraNeuroinflammation

摘要: Parkinson's disease (PD) is the second most common neurodegenerative disease, after Alzheimer's disease. The potential causes of PD remain uncertain, but recent studies suggest neuroinflammation and microglia activation play important roles in pathogenesis. Major unanswered questions include whether protein aggregates cause selective loss dopaminergic neurons substantia nigra that underlies clinical symptoms a consequence or nigral cell loss. Within microenvironment brain, glial cells critical role homeostatic mechanisms promote neuronal survival. Microglia have specialized immune surveillance mediate innate responses to invading pathogens by secreting myriad factors include, cytokines, chemokines, prostaglandins, reactive oxygen nitrogen species, growth factors. Some these neuroprotective trophic activities aid brain repair processes; while others enhance oxidative stress trigger apoptotic cascades neurons. Therefore, pro- anti-inflammatory must be balance prevent detrimental effects prolonged unregulated inflammation-induced on vulnerable populations. In this review, we discuss triggers review strongest direct evidence chronic may more versus other diseases. Alternatively, propose genetic deficiency not only way reduce protective which function keep microglial check regulate sensitivity DA If inflammation can shown decrease levels midbrain, essence haploinsufficiency such as Parkin RGS10 result from purely environmental (aging, systemic etc.), increasing vulnerability neuron death predisposing an individual development PD. Lastly, latest epidemiological experimental supporting use immunomodulatory drugs agents delay progressive nigrostriatal degeneration leads motor dysfunction

参考文章(138)
Francesca Aloisi, The role of microglia and astrocytes in CNS immune surveillance and immunopathology. Advances in Experimental Medicine and Biology. ,vol. 468, pp. 123- 133 ,(1999) , 10.1007/978-1-4615-4685-6_10
Hideki Mochizuki, T. Furuya, H. Arai, Yoko Mizuno, Inflammation and infection in Parkinson's disease. Histology and Histopathology. ,vol. 21, pp. 673- 678 ,(2006) , 10.14670/HH-21.673
Stéphane Hunot, Nathalie Dugas, Baptiste Faucheux, Andreas Hartmann, Marc Tardieu, Patrice Debré, Yves Agid, Bernard Dugas, Etienne C. Hirsch, FcεRII/CD23 Is Expressed in Parkinson’s Disease and Induces,In Vitro,Production of Nitric Oxide and Tumor Necrosis Factor-α in Glial Cells The Journal of Neuroscience. ,vol. 19, pp. 3440- 3447 ,(1999) , 10.1523/JNEUROSCI.19-09-03440.1999
Christophe Wersinger, Anita Sidhu, Inflammation and Parkinson's disease. Current Drug Targets - Inflammation & Allergy. ,vol. 1, pp. 221- 242 ,(2002) , 10.2174/1568010023344580
T. Breidert, J. Callebert, M. T. Heneka, G. Landreth, J. M. Launay, E. C. Hirsch, Protective action of the peroxisome proliferator‐activated receptor‐γ agonist pioglitazone in a mouse model of Parkinson's disease Journal of Neurochemistry. ,vol. 82, pp. 615- 624 ,(2002) , 10.1046/J.1471-4159.2002.00990.X
P S Whitton, Inflammation as a causative factor in the aetiology of Parkinson's disease. British Journal of Pharmacology. ,vol. 150, pp. 963- 976 ,(2007) , 10.1038/SJ.BJP.0707167
Tony Wyss-Coray, Tony Wyss-Coray, Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nature Medicine. ,vol. 12, pp. 1005- 1015 ,(2006) , 10.1038/NM1484
Nadia Benaroudj, Alfred L. Goldberg, PAN, the proteasome-activating nucleotidase from archaebacteria, is a protein-unfolding molecular chaperone. Nature Cell Biology. ,vol. 2, pp. 833- 839 ,(2000) , 10.1038/35041081